FMC Corp vs Kimberly Clark Corp — how do they compare? FMC Corp trades at $8.95 (market cap $1.39B), while Kimberly Clark Corp trades at $97.86 (market cap $32.51B). The key difference: Kimberly Clark Corp is far larger — about 23.4× FMC Corp's market cap, and Kimberly Clark Corp pays the higher dividend (5.24%). Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Kimberly Clark Corp for 93 Days on average.
| FMC | KMB | |
|---|---|---|
Market Cap | $1.39B | $32.51B |
Volume | 4,145,979 | 6,139,913 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $30.63 | $121.44 |
52-Week Low | $8.44 | $93.05 |
Typical Hold Time | 68 Days | 93 Days |
Enterprise Value | $5.19B | $38.07B |
Dividend Yield | 3.59% | 5.24% |
Signals from Pluang's Aura AI — not financial advice
FMC trades at $9.09, up 0.66% with bearish technical signals despite recent earnings beats. The agricultural sciences company faces severe profitability challenges with a -84.83% net margin and negative ROE, though valuation ratios appear attractive with P/S of 0.35 and P/B of 0.86. Recent developments include regulatory filings for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.
While analyst consensus suggests moderate upside to the $14.60 price target, significant operational challenges and negative cash flow from operations in 2025 present substantial risks. The company's aggressive deleveraging efforts and new product pipeline offer potential catalysts, but investors face headwinds from cyclical industry pressures and persistent profitability issues.
Kimberly-Clark (KMB) trades at $96.48, down 0.3% on the day, showing bearish technical signals with recent price weakness. The company maintains strong profitability with 11.79% net margins and 129.43% ROE, though revenue declined to $16.45B in 2025. Recent Q2 2026 earnings missed expectations, while analyst consensus remains cautiously optimistic with a $117.25 price target. Key developments include executive transitions and ongoing Kenvue acquisition negotiations with EU regulators.
KMB presents a mixed investment case with attractive 5.16% dividend yield and 54-year dividend growth streak, but faces execution risks from the Kenvue acquisition and cash flow pressures. The stock trades below analyst targets with bearish technical momentum, requiring careful monitoring of merger integration and cash flow sustainability for dividend investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →